Patents by Inventor Jakob Maria Bogenberger

Jakob Maria Bogenberger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7297482
    Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the library peptides and peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.
    Type: Grant
    Filed: March 18, 2003
    Date of Patent: November 20, 2007
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
  • Patent number: 6936421
    Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the library peptides and peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.
    Type: Grant
    Filed: June 20, 2002
    Date of Patent: August 30, 2005
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
  • Publication number: 20030224412
    Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the library peptides and peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.
    Type: Application
    Filed: March 18, 2003
    Publication date: December 4, 2003
    Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
  • Publication number: 20030143562
    Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the library peptides and peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.
    Type: Application
    Filed: June 20, 2002
    Publication date: July 31, 2003
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
  • Patent number: 6596485
    Abstract: The invention relates to the use of fluorescent proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the random peptides and random peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening random peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.
    Type: Grant
    Filed: December 27, 2000
    Date of Patent: July 22, 2003
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: David Anderson, Jakob Maria Bogenberger
  • Patent number: 6562617
    Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the random peptides and random peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening random peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.
    Type: Grant
    Filed: July 27, 2000
    Date of Patent: May 13, 2003
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
  • Patent number: 6548632
    Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the random peptides and random peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening random peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.
    Type: Grant
    Filed: October 8, 1999
    Date of Patent: April 15, 2003
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
  • Patent number: 6548249
    Abstract: The invention relates to the use of scaffold proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the random peptides and random peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening random peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.
    Type: Grant
    Filed: July 27, 2000
    Date of Patent: April 15, 2003
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: David Anderson, Beau Robert Peelle, Jakob Maria Bogenberger
  • Publication number: 20010003650
    Abstract: The invention relates to the use of fluorescent proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the random peptides and random peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening random peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.
    Type: Application
    Filed: December 27, 2000
    Publication date: June 14, 2001
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: David Anderson, Jakob Maria Bogenberger
  • Patent number: 6180343
    Abstract: The invention relates to the use of fluorescent proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the random peptides and random peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening random peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.
    Type: Grant
    Filed: October 8, 1998
    Date of Patent: January 30, 2001
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: David Anderson, Jakob Maria Bogenberger